Cite

HARVARD Citation

    Hastings, K. et al. (2019). EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer. Annals of oncology. pp. 1311-1320. [Online]. 
  
Back to record